Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-17 of 17 for Peripheral neuropathy

Edit search filters
  1. A Study to Analyze Skin and Nerve Cell Interactions in the Skin Biopsies of Patients who have Chemotherapy Induced Peripheral Neuropathy

    Rochester, MN

  2. A Study to Collect Blood Samples for Research Studies from Patients with Peripheral Neuropathy

    Rochester, MN

  3. A Study to Assess Educational Needs and Perceived Barriers to Care Among Individuals with Chronic Health Conditions and Their Caregivers

    Jacksonville, FL, Rochester, MN

  4. A Study of Chemotherapy-induced Peripheral Neuropathy in Hodgkin's Lymphoma Patients who Received Brentuximab Vedotin

    Rochester, MN

  5. A Study to Understand Symptoms from Olaparib

    Rochester, MN

  6. Stem Cells from Skin Fibroblasts in Patients with Hereditary Peripheral Neuropathy

    Rochester, MN

  7. A Study of Chemotherapy-induced Peripheral Neuropathy (EPIPHANY)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN


Mayo Clinic Footer